Singulair Vs. Claritin

Featured Article

The Food and Drug Administration is scheduled to review a new allergy medication for market approval. The med is a combination of the asthma drug Singulair and the allergy tablet Claritin. Drugmakers Schering-Plough and Merck are seeking approval of the combination for use by patients who have allergic rhinitis.

Read more

More information on "Singulair Vs. Claritin"

From Our Experts

See more SharePosts »

From Our Sources

More on Asthma »